Delivery Order SPE2DR25D2003-SPE2DR26FR14V
Award Date 1/30/26
Potential Completion Date 2/2/26
Potential Value $7.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on January 21, 2026, for Trulicity 1.5 mg/0.5 ml pen injections with a ceiling value of $2,842.99 and an ultimate completion date of January 22, 2026. This award utilizes a firm fixed-price contract structure and was competitively awarded with no set-aside designation. The delivery order falls under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,702.70 by the Defense Logistics Agency (DLA) on June 2, 2025, with an ultimate completion date of June 3, 2025. The delivery order is for Trulicity 1.5 mg/0.5 ml pen injectables and was issued under a firm fixed-price, non-set-aside competitive contract. This child delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 9, 2025, by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $22,414.82. The contract is a firm fixed price delivery order with an ultimate completion date of September 10, 2025, and was awarded without a set-aside designation through competitive procurement. Performance will be executed at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 2, 2026, by the Defense Logistics Agency for the supply of Trulicity 0.75 mg/0.5 ml pens valued at $1,424.16. The award represents a competitive, non-set-aside contract with firm fixed pricing and is scheduled for completion by January 5, 2026. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $2,084.00 by the Defense Logistics Agency (DLA) on January 14, 2026, with an ultimate completion date of January 15, 2026. The contract covers the supply of Trulicity 1.5 mg/0.5 ml pen injectable medication and is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,017.52 by the Defense Logistics Agency on November 24, 2025, with completion targeted for November 25, 2025. The contract (4570091594) involves the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL), a diabetes medication commonly used within military and federal healthcare systems. This delivery order was competitively awarded without set-aside...
- The Defense Logistics Agency awarded a $17,326.49 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injections on January 21, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 22, 2026. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters....
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on October 31, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injections. The contract, valued at $4,379.01, represents a firm fixed price delivery order with an ultimate completion date of November 3, 2025. The place of performance is identified as Conshohocken, Pennsylvania, which is AmerisourceBergen's corporate headquarters location. This award was competitively awarded without set-aside...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 15, 2026, for the supply of Trulicity 4.5 mg/0.5 mL pens in 0.5 mL dosages. This firm fixed-price delivery order, valued at $1,898.88, is scheduled for completion by January 16, 2026, and represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,494.17 by the Defense Logistics Agency on July 31, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors with a 0.5 ml dosage. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded through open competition. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...